Cellectar Biosciences, Inc. (CLRB)
1.25
+0.10
(+8.70%)
USD |
NASDAQ |
Nov 06, 16:00
1.24
-0.01
(-0.80%)
After-Hours: 20:00
Cellectar Biosciences Market Cap : 10.32M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 10.32M |
| November 05, 2026 | 9.490M |
| November 04, 2026 | 10.15M |
| November 03, 2026 | 10.81M |
| November 02, 2026 | 10.07M |
| October 30, 2026 | 9.944M |
| October 29, 2026 | 10.07M |
| October 28, 2026 | 10.23M |
| October 27, 2026 | 9.985M |
| October 26, 2026 | 9.985M |
| October 23, 2026 | 10.07M |
| October 22, 2026 | 9.655M |
| October 21, 2026 | 10.56M |
| October 20, 2026 | 10.15M |
| October 19, 2026 | 9.242M |
| October 16, 2026 | 9.407M |
| October 15, 2026 | 9.82M |
| October 14, 2026 | 9.738M |
| October 13, 2026 | 11.47M |
| October 12, 2026 | 11.80M |
| October 09, 2026 | 11.97M |
| October 08, 2026 | 11.55M |
| October 07, 2026 | 12.46M |
| October 06, 2026 | 12.46M |
| October 05, 2026 | 13.78M |
| Date | Value |
|---|---|
| October 02, 2026 | 14.69M |
| October 01, 2026 | 15.43M |
| September 30, 2026 | 15.18M |
| September 29, 2026 | 15.02M |
| September 28, 2026 | 15.10M |
| September 25, 2026 | 14.85M |
| September 24, 2026 | 17.12M |
| September 23, 2026 | 17.25M |
| September 22, 2026 | 18.40M |
| September 21, 2026 | 19.39M |
| September 18, 2026 | 19.64M |
| September 17, 2026 | 19.80M |
| September 16, 2026 | 19.39M |
| September 15, 2026 | 19.14M |
| September 14, 2026 | 19.06M |
| September 11, 2026 | 19.06M |
| September 10, 2026 | 19.56M |
| September 09, 2026 | 19.52M |
| September 08, 2026 | 19.89M |
| September 04, 2026 | 19.56M |
| September 03, 2026 | 19.39M |
| September 02, 2026 | 20.05M |
| September 01, 2026 | 20.30M |
| August 31, 2026 | 20.71M |
| August 28, 2026 | 20.88M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.654B |
| Alnylam Pharmaceuticals, Inc. | 20.88B |
| Anika Therapeutics, Inc. | 194.72M |
| Savara, Inc. | 992.08M |
| Vericel Corp. | 2.795B |
Market Cap Related Metrics
| Price to Book Value | 0.3453 |
| Price | 1.25 |
| Earnings Yield | -364.3% |